Dr. Stephanie Heaton Greco, MD

Dr. Greco practices at Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Greco's NPI, 1205154341, was assigned on May 13, 2010. Dr. Greco holds Pennsylvania license MD468407.

Dr. Greco's primary practice is Fox Chase Cancer Center, at 333 Cottman Avenue, Philadelphia, PA 19111.

Dr. Greco's primary practice is Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Greco is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Greco to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greco practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Greco's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Greco is licensed in Pennsylvania.

CMS data shows 518 Medicare services from Dr. Greco across 7 procedure codes in 2024, for 185 Medicare patients. Medicare paid $27,900 for them.

CMS counts 185 Medicare patients who saw Dr. Greco in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Greco's median patient age at 69, with 52% women.

In 2024, Dr. Greco wrote 97 Medicare Part D claims for 41 patients. 99% of them were for generic drugs. CMS names the drug for 73 of them, across 3 drugs with 11 or more claims each, at $269 in total drug cost. In 2023, CMS named 73 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Greco for performance year 2024, reported as part of a group. Dr. Greco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of melanoma (skin cancer) excision by Dr. Greco, more than 74% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Greco, published from 2013 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Mice, Inbred C57BL, Signal Transduction and Mice, Knockout. Dr. Greco has published most often in Ann Surg Oncol. Dr. Greco's most frequent co-authors are Jeffrey M. Farma, MD, Donnele Daley, MD and Anthony Michael Villano.

CMS Open Payments shows 20 general payments to Dr. Greco from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $2,971.